12:00 AM
 | 
Aug 14, 2000
 |  BC Week In Review  |  Company News  |  Deals

Active Biotech, Aventis, SmithKline Beecham plc deal

ACTI reacquired from SB global rights to ACTI’s Dukoral ETEC vaccine to prevent travelers’ diarrhea that is marketed in Sweden and Norway. ACTI also reobtained from SB the international marketing rights to its SBL...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >